sublingual tablets [Regulatives / Guidelines]

posted by drgunasakaran1  – 2013-02-06 09:40 (4887 d 14:56 ago) – Posting: # 9972
Views: 5,905

Dear Mr Amr Hussein,

❝ The necessity to do bioequivalence study for sublingual tablets especially isosorbid dinitrate 5mg tablets as it is totally absorbed from oromucosal cavity


Even FDA recommends to do Bioequivalence study for ANDA submission of Isosorbide dinitrate sublingual tablets.

Reference: FDA Docket No. 77N-0240; DESI 1786

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
153 visitors (0 registered, 153 guests [including 17 identified bots]).
Forum time: 01:36 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5